OR15 Novel Treatment for Diabetes - Focusing on GLP-1 and SGLT2

Program: Abstracts - Orals, Poster Previews, and Posters
Oral Session
Diabetes & Glucose Metabolism-Clinical
Saturday, April 2, 2016: 11:45 AM-1:15 PM
Room 157 (BCEC)
Chairs:
Jenny Tong, MD, MPH, Duke University, Durham, NC and Vivian A Fonseca, MD, Tulane University Health Science, New Orleans, LA

Disclosures:
VAF: Ad Hoc Consultant, Novo Nordisk, Ad Hoc Consultant, GlaxoSmithKline, Investigator, Lexicon Pharmaceuticals, Inc., Investigator, Bayer, Inc., Ad Hoc Consultant, Sanofi, Speaker, Takeda, Ad Hoc Consultant, Astra Zeneca. Nothing to Disclose: JT Disclosure Not Provided: LSC
11:45 AM
Christopher Sorli1, Shin-ichi Harashima2, George Tsoukas3, Jeffrey Unger4, Julie Derving Karsbøl5, Thomas Hansen5 and Stephen Bain6, (1)Billings Clinic Research Center, Billings, MT
(2)Graduate School of Medicine, Kyoto University, Kyoto, Japan
(3)Department of Medicine, McGill University, Montreal, Canada
(4)Catalina Research Institute, Chino, CA
(5)Novo Nordisk A/S, Søborg, Denmark
(6)School of Medicine, Swansea University, Swansea, United Kingdom
12:00 PM
Olivia M. Farr, PhD1, Michail Sofopoulos2, Michael A. Tsoukas, MD1, Fadime Dincer, MD3, Bindiya Thakkar4, Ayse Sahin-Efe, MD5, Andreas Filippaios3, Jennifer Bowers3, Alexandra Srnka3, Anna Gavrieli, PhD3, Byung-Joon Ko, MD, MPH3, Chrysoula Liakou2, Nickole Kanyuch3, Sofia Tseleni-Balafouta6 and Christos S. Mantzoros, MD, DSc, PhD7, (1)Division of Endocrinology, Diabetes and Metabolism, Department of Internal Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
(2)St. Savvas Anticancer-Oncology Hospital
(3)Harvard Medical School/ Beth Israel Deaconess Medical Center
(4)Harvard Medical School/ Beth Israel Deaconess Medical Center, Boston, MA
(5)Harvard Medical School/ Beth Israel Deaconess
(6)University of Athens, Medical School
(7)Endocrinology, BIDMC, Harvard, Boston, MA
12:15 PM
Serge Jabbour1, Thomas R Pieber2, Julio Rosenstock3, Marie-Louise Hartoft-Nielsen4, Oluf Kristian Højbjerg Hansen4 and Melanie Davies5, (1)Endocrinology, Thomas Jefferson University, PA
(2)Medical University of Graz, Austria
(3)Dallas Diabetes and Endocrine Center, TX
(4)Novo Nordisk A/S, Søborg, Denmark
(5)Diabetes Research Centre, University of Leicester, United Kingdom
12:30 PM
Kamlesh Khunti, University of Leicester, Leicester, United Kingdom, Sanjay Patel, MB ChB, Boehringer Ingelheim Ltd., Bracknell, United Kingdom, Egon Pfarr, Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany, Angelo Del Parigi, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT and Christopher Lee, Boehringer Ingelheim GmbH & Co. KG, Ingelheim, Germany
12:45 PM
Eric G. Vajda, Ph.D., Preclinical Research and Development, Ligand Pharmaceuticals Incorporated, La Jolla, CA, Douglas K. Logan, M.D., Medpace Clinical Pharmacology Unit, Medpace, Inc., Cincinnati, OH, Kenneth Lasseter, MD, Clinical Pharmacology of Miami, Miami, FL, Danielle Armas, MD, Celerion, Phoenix, AZ, Diane J. Plotkin, Ph.D., Diane Plotkin Clinical Development Consultation Services, Poway, CA, J. D. Pipkin, Ph.D., New Product Development, Ligand Pharmaceuticals Incorporated, La Jolla, CA, Yong-Xi Li, Ph.D., Medpace Bioanalytical Labs, Medpace, Inc., Cincinnati, OH, Rong Zhou, PhD, Biostatistics, Medpace, Cincinnati, OH, David J Klein, MD, MedPace, Inc., Cincinnati, OH, Xiaoxiong Wei, PhD, MedPace, Inc., Stacy Dilzer, Clinical Pharmacology of Miami, Lin Zhi, Ph.D., Chemistry and Pharm Sciences, Ligand Pharmaceuticals Incorporated, La Jolla, CA and Keith B. Marschke, Ph.D., Biology, Ligand Pharmaceuticals Incorporated, San Diego, CA
1:00 PM
Husam Ghanim, PhD1, Nitesh D Kuhadiya, MD, MPH2, Salman Khan, MD3, Manisha Garg, MD4, Kelly Green, BS5, Sanaa Abuaysheh, BS3 and Paresh Dandona, MD, PHD, FRCP, FACP, FACE6, (1)Endocrinology, Diabetes and Metabolism, University at Buffalo, Buffalo, NY
(2)University at Buffalo, Buffalo, NY
(3)Endocrinology, Suny at Buffalo
(4)Department of Endocrinology, Diabetes and Endocrinology Center of Western New York, Buffalo, NY
(5)SUNY at Buffalo
(6)Diabetes and Endocrinology Center of Western New York, Buffalo, NY

 

The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire